Recombinant cardiac ATP-sensitive K+ channel subunits confer resistance to chemical hypoxia-reoxygenation injury

Circulation

Volumn 98, Issue 15, 1998, Pages 1548-1555

  Jovanović, Aleksandar ^a   Jovanović, Sofija ^a   Lorenz, Eva ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

Calcium; Hypoxia; Ischemia; Potassium channels; Reperfusion

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; GLIBENCLAMIDE; MEMBRANE PROTEIN; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN KIR6 2; PROTEIN SUBUNIT; PROTEIN SUR2A; RECEPTOR; SULFONYLUREA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL HYPOXIA; CELL PROTECTION; CELL STRAIN COS1; CHANNEL GATING; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY;

EID: 0032514610     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.15.1548     Document Type: Article

References (40)

1. Gross GJ. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol. 1995;90:85-88.
2. Hearse DJ. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection. Cardiovasc Res. 1995;30:1-17.
3. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol. 1997;75:309-315.
4. Schwarz ER, Whyte WS, Kloner RA. Ischemic preconditioning. Curr Opin Cardiol. 1997;12:475-481.
5. + channels involves high-energy phosphate preservation. Am J Physiol. 1993;265:H1809-H1818.
6. + channel-opening drugs. Am J Physiol. 1995;269:C525-C545.
7. Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG. Anti-ischemic effect of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther. 1989;251:98-104.
8. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992; 70:223-233.
9. Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res. 1993;72:44-49.
10. ATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts. Eur J Pharmacol. 1995;277:271-274.
11. Grover GJ, D'Alonzo AJ, Hess T, Sleph PG, Darbenzio RB. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res. 1995;30:731-738.
12. + channels. Cardiovasc Drugs Ther. 1993;7:499-505.
13. + channel towards intracellular nucleoside diphosphates. Neuron. 1994;12:1049-1058.
14. Jenkins DP, Steare SE, Yellon DM. Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice. Cardiovasc Drugs Ther. 1995;9:739-747.
15. Przyklenk K, Hata K, Kloner RA. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium? Circulation. 1997;96:1305-1312.
16. Downey JM, Cohen MV. Signal transduction in ischemic preconditioning. Adv Exp Med Biol. 1997;430:39-55.
17. + channel. Biochem Pharmacol. 1997;54:219-225.
18. + channels: basis for channel opening. J Gen Physiol. 1998;111:381-394.
19. + channels toward sulfonylureas. Circ Res. 1998;82:272-278.
20. 2+ loading: insight into cardioprotection during cardioplegia. Ann Thorac Surg. 1998;65:586-591.
21. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP, Boyd AE, Gonzales G, Hererra-Sosa H, Nguy K, Bryan J, Nelson DA. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995;268:423-426.
22. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 1995;270: 1166-1170.
23. + channels. Neuron. 1996;16: 1011-1017.
24. + channel. J Biol Chem. 1996;271:24321-24324.
25. + channel behavior. J Membr Biol. 1997;159: 161-168.
26. + channel. Mol Cell Biol. 1998;18:1652-1659.
27. + channel expressed in a mammalian cell line, HEK293T cells. Pflugers Arch. 1998;435:595-603.
28. Jovanović A, Alekseev AE, Lopez JR, Shen WK, Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg. 1997;63:153-161.
29. 2+ waves: a laser confocal microscopy study. Am J Physiol. 1996;270:H1384-H1389.
30. 2+ loading in cardiomyocytes. Eur J Pharmacol. 1996;308:343-349.
31. ATP channels: operative state-dependent regulation by a nucleoside diphosphate. Pflugers Arch. 1996;431:800-802.
32. Granger DN, Korthius RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol. 1995;57:311-332.
33. 2+-overload in reperfused ischemic myocardium. Annu Rev Physiol. 1990;52:543-559.
34. 2+ transients in COS-7 cells transfected with the cDNA encoding skeletal-muscle ryanodine receptor carrying a mutation associated with malignant hyperthermia. Biochem J. 1994;301:661-665.
35. + channels in cardiac muscle. Nature. 1983; 305:147-148.
36. + channels. Circ Res. 1997;81:1072-1082.
37. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA. 1995;92:4666-4670.
38. 2+ and pH. J Physiol. 1995;485:283-296.
39. Bryan J, Aguilar-Bryan L. The ABCs of ATP-sensitive potassium channels: more pieces of the puzzle. Curr Opin Cell Biol. 1997;9:553-559.
40. ATP channel. Proc Natl Acad Sci USA. 1997;94:11969-11973.